Apr 07, 2008
|
Vertex Pharmaceuticals Announces Webcast of its Presentation at the Canaccord|Adams Hepatitis C Conference
|
|
Apr 07, 2008
|
Vertex Pharmaceuticals Announces the Date of its First Quarter 2008 Financial Results Conference Call and Webcast
|
|
Mar 31, 2008
|
Vertex Pharmaceuticals Announces Acceptance of Late-Breaker Abstract on Telaprevir, Investigational HCV Protease Inhibitor, for Presentation at EASL Annual Meeting
|
|
Mar 27, 2008
|
Vertex Announces Positive Results for VX-770, an Oral Investigational Agent That Targets a Defective Protein Responsible for Cystic Fibrosis
|
|
Mar 14, 2008
|
Vertex Pharmaceuticals Announces Webcast of its Presentation at the Cowen and Company 28th Annual Health Care Conference
|
|
Mar 13, 2008
|
Vertex Pharmaceuticals and Tibotec Announce Start of Phase 3 'ADVANCE' Study with Telaprevir in Treatment-Naive, Genotype 1 HCV Patients
|
|
Feb 29, 2008
|
Vertex Pharmaceuticals Announces Webcast of its Presentation at the Susquehanna Financial Group's Second Annual SIGnificant Options in Healthcare Conference
|
|
Feb 19, 2008
|
Vertex Pharmaceuticals Announces Completion of its Concurrent Public Offerings of Common Stock and Convertible Senior Subordinated Notes
|
|
Feb 13, 2008
|
Vertex Pharmaceuticals Announces Exercise of Over-Allotment Options by Underwriters of its Concurrent Public Offerings of Common Stock and Convertible Senior Subordinated Notes
|
|
Feb 12, 2008
|
Vertex Pharmaceuticals Announces Pricing of its Concurrent Public Offerings of Common Stock and Convertible Senior Subordinated Notes
|
|
Feb 11, 2008
|
Vertex Pharmaceuticals Reviews 2008 Business Priorities and Reports 2007 Financial Results
|
|
Feb 11, 2008
|
Vertex Pharmaceuticals Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Subordinated Notes
|
|
Feb 08, 2008
|
Vertex Pharmaceuticals Announces Webcast of its Presentation at the BIO CEO & Investor Conference 2008
|
|
Jan 31, 2008
|
Vertex Pharmaceuticals Announces Webcast of its Presentation at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
|
|
Jan 28, 2008
|
Vertex Pharmaceuticals Announces the Date of its Fourth Quarter and Full Year 2007 Financial Results Conference Call and Webcast
|
|
Jan 23, 2008
|
Vertex Pharmaceuticals to Begin Phase 3 Development of Telaprevir, Investigational Hepatitis C Protease Inhibitor
|
|
Jan 07, 2008
|
Vertex Pharmaceuticals Reports Progress in Development of Investigational HCV Drug Telaprevir and Provides Business Update
|
|
Jan 03, 2008
|
Vertex Pharmaceuticals Announces Webcast of its Presentation at the 26th Annual JPMorgan Healthcare Conference
|
|
Nov 21, 2007
|
Vertex Pharmaceuticals Announces Webcast of its Presentation at the CIBC World Markets 3rd Annual Mid & Small Cap 'Best Ideas' Conference
|
|
Nov 20, 2007
|
Vertex's Collaborator Merck Suspends Patient Enrollment in Clinical Trials of MK-0457 (VX-680) Pending Full Analysis of Clinical Data
|
|